Drew Holzapfel is a founding board member at Davos Alzheimer's Collaborative since August 2021. Prior to that, Drew has held various positions such as Managing Partner and Partner at High Lantern Group since April 2013. Drew is also a founding board member at the Global Alzheimer's Platform Foundation since January 2016. With a background in marketing and political science, Drew has worked in reputable organizations such as Pfizer, VeriChip Corporation, and the Department of Health and Human Services. Drew's experience ranges from senior account executive roles to briefing coordinator positions, showcasing a diverse and accomplished career.
This person is not in any offices
Davos Alzheimer's Collaborative
Launched at the World Economic Forum’s 2021 meeting on The Davos Agenda, The Davos Alzheimer’s Collaborative is a multi-stakeholder partnership committed to aligning stakeholders with a new vision for our collective global response against the challenges Alzheimer’s presents to patients, caregivers and healthcare infrastructures. Convened by The World Economic Forum and The Global CEO Initiative on Alzheimer’s Disease (CEOi) and fueled by a mission of service to the estimated 150 million families and half a billion people inevitably impacted by this disease by 2050, DAC is a collaborative for the benefit of all people, in all places.